SIRNAOMICS-B Reports Annual Results: Net Loss Narrows by 70.93% to $14.605 Million

Stock News03-27

SIRNAOMICS-B (02257) announced its financial results for the year ended December 31, 2025. The Group's research and development expenses were $10.311 million, a decrease of 50.43% year-on-year. The annual net loss was $14.605 million, representing a significant reduction of 70.93% compared to the previous year.

According to the announcement, the decrease in the annual loss was primarily attributable to a reduction in the fair value loss on financial assets measured at fair value through profit or loss, lower administrative expenses, and decreased R&D spending. These factors were partially offset by a decrease in the fair value gain on financial liabilities measured at fair value through profit or loss.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment